X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://www.fiercepharma.com/pharma/takeda-hit-another-pay-delay-lawsuit-time-colcrys
https://www.business-standard.com/article/news-cm/zydus-life-gets-usfda-nod-for-lubiprostone-capsules-123032400856_1.html#:~:text=Zydus%20Lifesciences%20said%20that%20it,reference%20listed%20drug%2C%20Amitiza%20capsules.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206994
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209920
https://www.fiercepharma.com/pharma/mallinckrodt-investors-stream-for-exits-as-opioid-tied-bankruptcy-talk-mounts
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209450
https://www.genengnews.com/lists/5-biopharma-trends-to-watch-in-2019/
https://www.fiercepharma.com/manufacturing/mallinckrodt-spinoff-to-include-seven-manufacturing-sites-u-s-and-japan
https://www.reuters.com/article/us-mallinckrodt-spinoff/mallinckrodt-to-spin-off-generics-business-but-to-keep-options-open-idUSKBN1O516U
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-21-2018-1542783991.pdf
https://www.pharmacompass.com/pdf/news/amitiza-lubiprostone-sucampo-pharmaceuticals-vs-sun-pharmaceutical-1543986787.pdf
https://www.fiercepharma.com/pharma/3-5-years-and-no-deal-bruised-trulance-maker-synergy-desperate-for-new-funding
http://www.pmlive.com/pharma_news/mallinckrodt_pays_$1.2bn_for_sucampo_pharma_1215000
https://endpts.com/on-a-deal-spree-mallinckrodt-bags-sucampo-and-2-late-stage-rare-disease-drugs-for-1-2b/
https://www.pharmacompass.com/pdf/news/amitiza-lubiprostone-sucampo-takeda-v-amneal-pharmaceuticals-1494838268.pdf
http://www.fiercepharma.com/marketing/synergy-preps-for-constipation-market-assault-competitive-trulance-price-experienced-reps
http://www.fiercebiotech.com/biotech/purdue-inks-shionogi-collab-constipation-med-as-it-awaits-fda-approval
http://investor.sucampo.com/phoenix.zhtml?c=201197&p=irol-newsArticle&ID=2002365
Market Place
Share 
